Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Infect Dis ; 195(7): 951-9, 2007 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-17330784

RESUMO

BACKGROUND: A population-based phylogenetic approach was used to characterize human immunodeficiency virus (HIV)-transmission dynamics in Quebec. METHODS: HIV-1 pol sequences included primary HIV infections (PHIs; <6 months after seroconversion) from the Quebec PHI cohort (1998-2005; n=215) and the provincial genotyping program (2001-2005; n=481). Phylogenetic analysis determined sequence interrelationships among unique PHIs (n=593) and infections from untreated (n=135) and treated (n=660) chronically infected (CI) potential transmitter populations (2001-2005). Clinical features, risk factors, and drug resistance for clustered and nonclustered transmission events were ascertained. RESULTS: Viruses from 49.4% (293/593) of PHIs cosegregated into 75 transmission chains with 2-17 transmissions/cluster. Half of the clusters included 2.7+/-0.8 (mean+/-SD) transmissions, whereas the remainder had 8.8+/-3.5 transmissions. Maximum periods for onward transmission in clusters were 15.2+/-9.5 months. Coclustering of untreated and treated CIs with PHIs were infrequent (6.2% and 4.8%, respectively). The ages, viremia, and risk factors were similar for clustered and nonclustered transmission events. Low prevalence of drug resistance in PHI supported amplified transmissions at early stages. CONCLUSIONS: Early infection accounts for approximately half of onward transmissions in this urban North American study. Therapy at early stages of disease may prevent onward HIV transmission.


Assuntos
Transmissão de Doença Infecciosa , Farmacorresistência Viral/genética , Genes pol , Infecções por HIV/epidemiologia , Infecções por HIV/transmissão , HIV-1/genética , Adulto , Fármacos Anti-HIV/uso terapêutico , DNA Viral/análise , Feminino , Variação Genética , Infecções por HIV/tratamento farmacológico , Infecções por HIV/etiologia , Infecções por HIV/virologia , HIV-1/classificação , Humanos , Masculino , Filogenia , Quebeque/epidemiologia , Fatores de Risco
2.
Eur J Immunol ; 35(6): 1906-17, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15902687

RESUMO

Modulation of the phagocyte protein tyrosine phosphatase (PTP) SHP-1 by the parasite Leishmania favors its survival and propagation within its mammalian host. In vivo, the absence of SHP-1 leads to virtually absent footpad swelling, accompanied by enhanced inducible nitric oxide synthase expression. In this study, using an air pouch model, we show that viable motheaten SHP-1-deficient mice harbored a stronger inflammatory response against Leishmania infection than wild-type mice. This response was portrayed by higher pro-inflammatory cytokine (TNF-alpha, IL-1beta and IL-6) expression and secretion and by greater chemokine and chemokine receptor expression. These inflammatory molecules were probably responsible for the stronger cellular recruitment, mainly of neutrophils, seen at the site of infection in viable motheaten mice within 6 h post inoculation. We also provide strong evidence that protein tyrosine phosphatases in general, and SHP-1 in particular, are important regulators of chemokine gene expression. Overall, this study suggests that the ability of Leishmania to induce SHP-1 activity in its host allows the taming of an otherwise strong innate inflammatory response that would be detrimental for its survival and progression.


Assuntos
Inflamação/etiologia , Leishmaniose/imunologia , Proteínas Tirosina Fosfatases/fisiologia , Animais , Quimiocina CXCL2 , Quimiocinas/genética , Regulação da Expressão Gênica , Inflamação/imunologia , Interleucina-1/biossíntese , Interleucina-6/biossíntese , Peptídeos e Proteínas de Sinalização Intracelular , Leucócitos/fisiologia , Macrófagos/parasitologia , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Proteína Tirosina Fosfatase não Receptora Tipo 6 , Fator de Necrose Tumoral alfa/genética
3.
AIDS ; 18(3): 427-31, 2004 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-15090794

RESUMO

BACKGROUND: Heterosexual transmission of HIV-1 is the major route of infection worldwide. HLA-G molecules are involved in the inhibition of cell-mediated immune responses and could permit or even promote the propagation of infection in the female reproductive tract. OBJECTIVE: To examine whether HLA-G genetic variants are associated with the risk of heterosexual HIV-1 infection. METHODS: HLA-G polymorphism in DNA samples from 431 (228 HIV-positive and 203 HIV-negative) Zimbabwean women was determined by amplified-restriction fragment length polymorphism and DNA sequencing analyses. RESULTS: Six HLA-G alleles were identified in the study population. HLA-G*0105N, which does not encode functional HLA-G1 proteins, was significantly associated with protection from HIV-1 infection [odds ratio (OR), 0.51; 95% confidence interval (CI), 0.31-0.85; P = 0.0083). The HLA-G*010108 allele was associated with a 2.5-fold increased risk of HIV-1 infection (OR, 2.47; 95% CI, 1.32-4.64; P = 0.0038). In addition, two HLA-G*010108-containing genotypes were associated with elevated risk of HIV-1 infection: HLA-G*010108/010401 (OR, 23.6; 95% CI, 1.39-401.7; P = 0.0009) and G*010101/010108 (OR, 5.6; 95% CI, 1.24-25.3; P = 0.012). CONCLUSION: This study demonstrates that functionally active HLA-G polymorphisms are associated with altered risk of HIV-1 infection in African women. This provides evidence to support the hypothesis that modulation of HLA-G expression by HIV-1 can contribute to the risk of infection. Targeted interventions to reduce or block HLA-G expression in genital tissues could lead to novel strategies for the prevention of heterosexual HIV-1 transmission.


Assuntos
Infecções por HIV/transmissão , HIV-1 , Antígenos HLA/genética , Antígenos de Histocompatibilidade Classe I/genética , Polimorfismo Genético , Países em Desenvolvimento , Feminino , Frequência do Gene , Predisposição Genética para Doença , Infecções por HIV/genética , Antígenos HLA-G , Heterossexualidade , Humanos
4.
Infect Immun ; 71(11): 6499-509, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14573672

RESUMO

Leishmania is an intracellular pathogen that replicates inside macrophages. Activated macrophages produce a specific subset of cytokines that play an important role in the control of Leishmania infections. As part of our interest in developing suicide parasites that produce abortive infections for the purposes of vaccination, we engineered recombinant Leishmania major strains producing biologically active granulocyte-macrophage colony-stimulating factor (GM-CSF). We showed that GM-CSF is being produced in the phagosomes of infected macrophages and that it can be detected in the culture supernatants of both infected macrophages and extracellular parasites. Our data support the notion that GM-CSF secreted by both developmental forms of recombinant L. major can activate macrophages to produce high levels of proinflammatory cytokines such as interleukin-1beta (IL-1beta), IL-6, and IL-18 and various chemokines including RANTES/CCL5, MIP-1alpha/CCL3, MIP-1beta/CCL4, MIP-2/CXCL2, and MCP-1/CCL2, which enhance parasite killing. Indeed, GM-CSF-expressing parasites survive poorly in macrophages in vitro and produce delayed lesion development in susceptible BALB/c mice in vivo. Selective killing of intracellular Leishmania expressing cytokine genes capable of activating cellular responses may constitute a promising strategy to control and/or prevent parasitic infections.


Assuntos
Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Leishmania major/imunologia , Leishmaniose Cutânea/prevenção & controle , Macrófagos/imunologia , Animais , Linhagem Celular , Células Cultivadas , Humanos , Interleucina-1/fisiologia , Interleucina-18/fisiologia , Interleucina-6/fisiologia , Ativação de Macrófagos , Macrófagos/microbiologia , Camundongos , Camundongos Endogâmicos BALB C , Óxido Nítrico/biossíntese , Proteínas Recombinantes
6.
Hum Immunol ; 63(6): 495-501, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12039526

RESUMO

Human leukocyte antigen G (HLA-G) is a nonclassical HLA class I antigen that is predominantly expressed on invasive cytotrophoblastic cells, and is postulated to be a mediator of maternal-fetal tolerance. Almost all studies in Caucasian and Asian populations have consistently reported that HLA-G exhibits low levels of allelic polymorphism unlike the classical class I genes. However, the concept that HLA-G is nonpolymorphic has recently been challenged in a single study of African-American subjects. We have examined the DNA sequences of the first seven HLA-G exons by single-strand conformational polymorphism (SSCP) and DNA direct sequencing procedures in 45 healthy individuals from an indigenous African population. Overall, we detected 14 sequence variations: 3 in the signal peptide (exon 1); 2 in the alpha-1 domain (exon 2); 5 in the alpha-2 domain (exon 3); 2 in alpha-3 domain (exon 4); 2 in transmembrane domain (exon 5); and none in the cytoplasmic tail (exons 6 and 7). Of these variants, only three result in amino acid substitutions at the protein level. Of particular interest, we identified a novel nucleotide substitution (C727T), 56 bp before the HLA-G gene transcription start site, located in the putative binding site for polyomavirus enhancer-binding protein 2 (PEBP2) transcriptor factor. These data confirm previous reports describing HLA-G exhibiting limited allelic polymorphism. Further studies are needed to determine the impact of the C727T polymorphism on the level or developmental regulation of HLA-G expression.


Assuntos
Antígenos HLA/genética , Antígenos de Histocompatibilidade Classe I/genética , Polimorfismo Genético , África Oriental , Sequência de Bases , População Negra/genética , Éxons , Antígenos HLA-G , Humanos , Dados de Sequência Molecular , Polimorfismo Conformacional de Fita Simples
7.
J Infect Dis ; 185(5): 673-81, 2002 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-11865425

RESUMO

This study investigated whether Leishmania species, the etiologic agent of cutaneous (Leishmania major) and visceral (Leishmania donovani) leishmaniasis, could differentially elicit early inflammatory events in vivo correlating with the subsequent development of their reciprocal pathogenesis. By use of the murine air pouch system, injection of Leishmania led to a rapid and transient accumulation of a mixed population of leukocytes, and L. major recruited 31-fold more leukocytes than did controls, compared with 7-fold more leukocytes for L. donovani. L. major promastigotes were better than L. donovani promastigotes at inducing proinflammatory cytokine secretion and chemokine gene expression in pouch exudates. L. major infection elicited significantly increased chemokine receptor gene expression, compared with L. donovani infection. Collectively, the data reveal that L. major is a strong inducer of the early inflammatory response, compared with L. donovani, and suggest that such an immunologic event potentially could restrain this parasite to the inoculation site, favoring the development of local swelling and cutaneous lesions.


Assuntos
Quimiotaxia de Leucócito/imunologia , Inflamação/imunologia , Leishmania donovani/imunologia , Leishmania major/imunologia , Receptores de Quimiocinas/metabolismo , Animais , Mediadores da Inflamação/metabolismo , Leishmania donovani/patogenicidade , Leishmania major/patogenicidade , Leishmaniose Cutânea/imunologia , Leishmaniose Cutânea/parasitologia , Leishmaniose Visceral/imunologia , Leishmaniose Visceral/parasitologia , Leucócitos/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Receptores de Quimiocinas/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA